Opening book details…
About this nonfiction
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial by Zaanan, Aziz (author);Bouché, Olivier (author);de la Fouchardière, Christelle (author);Le Malicot, Karine (author);Pernot, Simon (author);Louvet, Christophe (author);Artru, Pascal (author);Le Brun Ly, Valérie (author);Aldabbagh, Kais (author);Khemissa-Akouz, Faiza (author);Lecomte, Thierry (author);Castanie, Hélène (author);Laly, Margot (author);Botsen, Damien (author);Roth, Gael (author);Samalin, Emmanuelle (author);Muller, Marie (author);Breysacher, Gilles (author);Manfredi, Sylvain (author);Phelip, Jean-Marc (author);Taieb, Julien (author) is a nonfiction available to read on EtoBox.
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Zaanan, Aziz (author);Bouché, Olivier (author);de la Fouchardière, Christelle (author);Le Malicot, Karine (author);Pernot, Simon (author);Louvet, Christophe (author);Artru, Pascal (author);Le Brun Ly, Valérie (author);Aldabbagh, Kais (author);Khemissa-Akouz, Faiza (author);Lecomte, Thierry (author);Castanie, Hélène (author);Laly, Margot (author);Botsen, Damien (author);Roth, Gael (author);Samalin, Emmanuelle (author);Muller, Marie (author);Breysacher, Gilles (author);Manfredi, Sylvain (author);Phelip, Jean-Marc (author);Taieb, Julien (author)
- Publisher
- Elsevier BV
- Published
- 2025
- Language
- EN
- Category
- nonfiction
More by Zaanan, Aziz (author);Bouché, Olivier (author);de la Fouchardière, Christelle (author);Le Malicot, Karine (author);Pernot, Simon (author);Louvet, Christophe (author);Artru, Pascal (author);Le Brun Ly, Valérie (author);Aldabbagh, Kais (author);Khemissa-Akouz, Faiza (author);Lecomte, Thierry (author);Castanie, Hélène (author);Laly, Margot (author);Botsen, Damien (author);Roth, Gael (author);Samalin, Emmanuelle (author);Muller, Marie (author);Breysacher, Gilles (author);Manfredi, Sylvain (author);Phelip, Jean-Marc (author);Taieb, Julien (author)
Similar books
- Zolbetuximab Plus mFOLFOX6 in Patients with CLDN18.2-positive, HER2-negative, Untreated, Locally Advanced Unresectable or Metastatic Gastric or Gastro-oesophageal Junction Adenocarcinoma (SPOTLIGHT): a Multicentre, Randomised, Double-blind, Phase 3 Trial — Shitara, Kohei; Lordick, Florian; Bang, Yung-Jue; Enzinger, Peter; Ilson, David; Shah, Manish A; Van Cutsem, Eric; Xu, Rui-Hua; Aprile, Giuseppe; Xu, Jianming; Chao, Joseph; Pazo-Cid, Roberto; Kang, Yoon-Koo; Yang, Jianning; Moran, Diarmuid; Bhattacharya, Pranob; Arozullah, Ahsan; Park, Jung Wook; Oh, Mok; Ajani, Jaffer A (2023)
- Pembrolizumab Plus Trastuzumab and Chemotherapy for HER2-positive Gastric or Gastro-oesophageal Junction Adenocarcinoma: Interim Analyses from the Phase 3 KEYNOTE-811 Randomised Placebo-controlled Trial — Janjigian, Yelena Y; Kawazoe, Akihito; Bai, Yuxian; Xu, Jianming; Lonardi, Sara; Metges, Jean Phillipe; Yanez, Patricio; Wyrwicz, Lucjan S; Shen, Lin; Ostapenko, Yuriy; Bilici, Mehmet; Chung, Hyun Cheol; Shitara, Kohei; Qin, Shu-Kui; Van Cutsem, Eric; Tabernero, Josep; Li, Kan; Shih, Chie-Schin; Bhagia, Pooja; Rha, Sun Young (2023)
- Cadonilimab with Chemotherapy in HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma: the Phase 1b/2 COMPASSION-04 Trial — Xiangyu Gao & Ke Ji & Yongning Jia & Fei Shan & Ye Chen & Nong Xu & Ziyu Jia & Tianshu Liu & Nong Yang & Haijun Zhong & Changzheng Li & Zengqing Guo & Qingxia Fan & Xiaoyan Lin & Yan Zhang & Hui Ren & Hongxia Yang & Zhifang Yao & Wei Liu & Zhongmin... (2024)
- First-line Cadonilimab Plus Chemotherapy in HER2-negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Randomized, Double-blind, Phase 3 Trial — Lin Shen & Yanqiao Zhang & Ziyu Li & Xiaotian Zhang & Xiangyu Gao & Bo Liu & Yusheng Wang & Yi Ba & Ning Li & Ruixing Zhang & Jingdong Zhang & Ye Chen & Jian Chen & Mingzhu Huang & Yang Fu & Mulin Liu & Zheng Liu & Jun Zhao & Wei Li & Jia Wei &... (2025)
- Claudin-18 Isoform 2-specific CAR T-cell Therapy (satri-cel) Versus Treatment of Physician's Choice for Previously Treated Advanced Gastric or Gastro-oesophageal Junction Cancer (CT041-ST-01): a Randomised, Open-label, Phase 2 Trial — Changsong Qi MD & Chang Liu MD & Prof Zhi Peng MD & Prof Yanqiao Zhang MD & Prof Jia Wei MD & Prof Wensheng Qiu MD & Prof Xiaotian Zhang MD & Prof Hongming Pan MD & Zuoxing Niu MSc & Prof Meng Qiu MD & Prof Yanru Qin MD & Prof Weijia Fang MD & Prof... (2025)
- Laparoscopic Versus Open Pancreatoduodenectomy for Pancreatic or Periampullary Tumours: a Multicentre, Open-label, Randomised Controlled Trial — Wang, Min; Li, Dewei; Chen, Rufu; Huang, Xiaobing; Li, Jing; Liu, Yahui; Liu, Jianhua; Cheng, Wei; Chen, Xuemin; Zhao, Wenxing; Li, Jingdong; Tan, Zhijian; Huang, Heguang; Li, Deyu; Zhu, Feng; Qin, Tingting; Ma, Jingdong; Yu, Guangsheng; Zhou, Baoyong; Zheng, Shangyou; Tang, Yichen; Han, Wei; Meng, Lingyu; Ke, Jianji; Feng, Chen, Botao; Yin, Xinmin; Chen, Weibo; Ma, Hongqin; Xu, Jian; Liu, Yifeng; Lin, Ronggui; Dong, Yadong; Yu, Yahong; Liu, Jun; Zhang, Hang; Qin, Renyi (2021)